Ask Warren

Dong-A ST

170900 · KOSPI · ₩170900 · 동아에스티

₩34,900▲ ₩1,000 (2.95%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −23.69%
Market cap
₩340B
Enterprise value
₩606B
P/E
39.1×
P/B
0.5×
Dividend yield
1.9%
ROE
1.3%
Net margin
1.0%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−38.2% from the high

₩31,600Today: ₩33,450 – ₩35,500₩56,462

Returns

  • 1W−3.3%
  • 1M+1.3%
  • 3M−2.6%
  • 6M−23.0%
  • YTD−30.3%
  • 1Y−23.7%
Volume today
33,197
5.3× the 20-day average
Traded today
₩1.2B
Listed shares
9,727,881
EPS (12 months)
₩893
Earnings yield 2.6%
SellBuy
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

XfWATGr/in@

Why is it moving?

+3.0% on Oct 27, 2026. Trading value 5.3× its normal.

Dong-A ST reported higher sales and operating profit for the third quarter, according to Chosun Biz. The company also held an investor relations event and published a preliminary earnings filing on the same day.

AI summary of the news and filings linked. It can be wrong; check them.

Possible reasons, not certainties. Not financial advice.

Signals

69Warming up
  • BuzzRisingBuzz 69: heavy trading.
  • SentimentPositiveNews: Headline reports sales and operating profit both rising in Q3. Community: 0 bullish, 0 bearish posts this week.
  • MomentumFlat0.1% over the last month; the price is above its 20-day average.
  • News impactSome8 news items and filings in two weeks; 0 rated high impact, 1 medium.
  • StreetSteady1 brokers, average target 46% from the price; last 30 days: 0 raised, 0 cut.

Signals describe activity, not recommendations. Not financial advice.

Dong-A ST stock overview

Dong-A ST (동아에스티, KRX: 170900) is listed on KOSPI, in the Biotech & Pharma sector. The company was spun off in March 2013 from Donga Socio Holdings (formerly Donga Pharmaceutical) and manufactures and sells prescription drugs, medical devices, and quasi-drugs, with its main business in prescription pharmaceuticals. Its shares closed at ₩34,900 on Oct 27, 2026, up 2.95% on the day, giving it a market value of ₩340B.

Key facts

Market cap
₩340B
Sector
Biotech & Pharma
Latest price change
+2.95%
As of
Oct 27, 2026
Main business
The company was spun off in March 2013 from Donga Socio Holdings (formerly Donga Pharmaceutical) and manufactures and sells prescription drugs, medical devices, and quasi-drugs, with its main business in prescription pharmaceuticals.

Quick answers about Dong-A ST

What does Dong-A ST do?
The company was spun off in March 2013 from Donga Socio Holdings (formerly Donga Pharmaceutical) and manufactures and sells prescription drugs, medical devices, and quasi-drugs, with its main business in prescription pharmaceuticals. Its products include the growth hormone Growtropin (Gróthrotopin), Motilitone, Suganon, and Gaster, and it operates manufacturing campuses in Cheonan, Daegu, and Songdo, with overseas sales including beverages such as Canbacus. The company is also developing new drugs for metabolic diseases such as diabetes, obesity, and MASH.
What is the market cap of Dong-A ST?
The market capitalisation of Dong-A ST was ₩340B at the close on Oct 27, 2026.
What is the analyst target price for Dong-A ST?
The average target price of 1 broker covering Dong-A ST is ₩51,000 (range ₩51,000 to ₩51,000), 46.1% above versus the latest price, based on each broker's latest public report within six months.
Who are the largest shareholders of Dong-A ST?
According to the latest official filings, the largest reported holders are Dong-A Pharmaceutical (41.52%, as of Oct 22, 2026); Dong-A Socio Holdings (41.52%, as of Mar 31, 2026); National Pension Service (4.78%, as of Jul 1, 2026).
When is the next earnings report from Dong-A ST?
Korean companies rarely announce results dates in advance. Based on when Dong-A ST filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Does the National Pension Service own Dong-A ST?
Yes. The National Pension Service held 4.78% of Dong-A ST shares as of Jul 1, 2026.

Company profile

The company was spun off in March 2013 from Donga Socio Holdings (formerly Donga Pharmaceutical) and manufactures and sells prescription drugs, medical devices, and quasi-drugs, with its main business in prescription pharmaceuticals. Its products include the growth hormone Growtropin (Gróthrotopin), Motilitone, Suganon, and Gaster, and it operates manufacturing campuses in Cheonan, Daegu, and Songdo, with overseas sales including beverages such as Canbacus. The company is also developing new drugs for metabolic diseases such as diabetes, obesity, and MASH.

Written by AI from the company's latest annual report.

Korean name
동아에스티
Sector
Biotech & Pharma
Themes
Biotech (new drugs)Contract drug manufacturing (CDMO)Obesity drugsPharmaceuticals
CEO
정재훈
Founded
Mar 2013
Listed
Apr 2013
Listed shares
9,727,881
Fiscal year ends
Month 12
Website
www.donga.co.kr

Similar companies

Recent news

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Dong-A ST / 동아에스티 / 170900 / KRX:170900

Source: KRX statistical information